No abstract available
Keywords:
disease modeling and treatment; hiPSC-derived cardiac cells; human cardiac pathophysiology; human induced pluripotent stem cell (hiPSC); multicellular 3D cardiac models.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Netherlands Organisation for Health Research and Development ZonMW (PSIDER no. 10250022110004), the European Research Council (ERC-CoG Mini-HEART no. 101001746), NextGenerationEU—Funding proposals by the beneficiaries of the calls Marie Sklodowska-Curie Individual Fellowships—MSCA-IF (Project No. H45E22001210006), CARIPLO Foundation—Biomedical Research Conducted by Young Researchers (Project No. 2019-1691), Single Ventricle Research Fund (SVRF) Additional Ventures and the Italian Ministry of University and Research (MUR) under the PRIN funding program (Research Projects of Significant National Interest, Project No. 20223L2C9N).